drugset / Trial / NCT04882228
Phase 4 Study to Evaluate Efficacy and Safety of Entelon Tab.150mg in Patients With Chronic Venous Disease(CVD)
RandomizedParallel-groupDouble-blindTreatment
Summary
This clinical trial is a multi-center, double-blind, randomized, active controlled , parallel design, non-inferiority phase 4 study to evaluate the efficacy and safety of Entelon 150mg in 278 patients with chronic venous disease.
Timeline
- Start
- 2021-01-28
- Primary completion
- 2022-02-28
- Completion
- 2022-02-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Purified and Micronized Flavonoid Fraction | Unknown | 500 mg | — |
| Subject | Vitis Vinifera Seed Dreid Extract | Unknown | 150 mg | — |